BOSTON--(BUSINESS WIRE)--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and ...
GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon ...
908 Devices (MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ Maven for automated control of glucose and lactate levels in cell cultures. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results